Q2058 Obecbtge autol up to 400 mil

Obecabtagene autoleucel, 10 up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per infusion

• Medicare coverage: Carrier judgment
• Status: active (July 2026 file)
• MUE: max 1 units per day (practitioner), rationale: Code Descriptor / CPT Instruction